EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma

Yaru Zhao, Chenlei Wen, Qi Wang, Yue Qing, Serena Tondi, Chiara Reina, Berina Šabanović, Cherry Yin-Yi Chang, Chu-Hu Lai, Huimin Wang, Mette Ø Agerbaek, Thomas M Clausen und 8 weitere

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2025. Verfasst von Yaru Zhao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Antigens, Protozoan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, H2020 European Research Council, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge for early diagnosis due to the lack of sensitive and specific biomarkers. This encouraged us to explore the diagnostic value of cancer‐derived small extracellular vesicles (sEVs) as early detection biomarkers. We previously showed that the recombinant malaria protein VAR2CSA (rVAR2) selectively binds to oncofetal chondroitin sulfate (ofCS) on the surfaces of cancer cells, which might be useful for identifying cancer‐derived sEVs. Indeed, flow cytometry revealed strong ofCS expression in PDAC cell‐derived sEVs, as evidenced by the presence of mutant KRAS , a common genetic alteration in PDAC. Plasma from PDAC patients showed significantly higher ofCS + sEV levels compared to healthy donors and patients with benign gastrointestinal diseases. ROC analysis for ofCS + sEVs revealed an AUC of 0.9049 for the detection of all‐stage and 0.9222 for early‐stage PDAC. Notably, mutant KRAS was also detected in these patient‐derived sEVs. Most intriguingly, combining ofCS + sEVs and CA19‐9 resulted in an AUC of 0.9707 for the detection of early PDAC. Our study demonstrates that rVAR2 is suitable for detecting ofCS + cancer‐derived sEVs in plasma, thereby providing high efficiency for identifying PDAC patients among a diverse population. These findings suggest that rVAR2‐based sEV detection could serve as a powerful diagnostic tool to improve patient survival through early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesPancreatic NeoplasmsCarcinoma, Pancreatic DuctalAntigens, ProtozoanHumansBiomarkers, TumorMaleFemaleMiddle AgedAgedProto-Oncogene Proteins p21(ras)Chondroitin SulfatesEarly Detection of CancerCell Line, Tumor

Stichwörter der Autor:innen

Early diagnosisextracellular vesiclesoncofetal chondroitin sulfatepancreatic ductal adenocarcinomarecombinant malaria protein

Substanzen

Biomarkers, TumorVAR2CSA protein, Plasmodium falciparumAntigens, ProtozoanProto-Oncogene Proteins p21(ras)Chondroitin SulfatesKRAS protein, human

Autor:innen und Institutionen

  • Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Research Institute of Pancreatic Disease, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Pancreatic Disease Center, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Institute of Digestive Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Pancreatic Cancer Heterogeneity, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Turin, Italy.

ORCID-Profile: Christopher Heeschen

Förderung

  • Ministry of Science and Technology, Taiwan
  • H2020 European Research Council
  • National Natural Science Foundation of China
  • FP7 Ideas: European Research Council
  • Shanghai Municipal Education Commission
  • National Nordic Foundation
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Shanghai Pujiang Program

Zitieren

APA

Zhao, Y., Wen, C., Wang, Q., Qing, Y., Tondi, S., Reina, C., Šabanović, B., Chang, C. Y., Lai, C. H., Wang, H., Agerbaek, M. Ø., Clausen, T. M., Gustavsson, T., Theander, T. G., Salanti, A., Meny, C. C., Shen, B., Aicher, A., Tang, J., & Heeschen, C. (2025). Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70067

Vancouver

Zhao Y, Wen C, Wang Q, Qing Y, Tondi S, Reina C, et al. Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70067

BibTeX
@article{Zhao2025,
  author = {Zhao, Yaru and Wen, Chenlei and Wang, Qi and Qing, Yue and Tondi, Serena and Reina, Chiara and Šabanović, Berina and Chang, Cherry Yin-Yi and Lai, Chu-Hu and Wang, Huimin and Agerbaek, Mette Ø and Clausen, Thomas M and Gustavsson, Tobias and Theander, Thor G and Salanti, Ali and Meny, Clara Csilla and Shen, Baiyong and Aicher, Alexandra and Tang, Jiajia and Heeschen, Christopher},
  title = {Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70067}
}
Kostenlos starten →